Top 5 Rising Stocks To Own For 2014

Average industry glide paths “should reasonably meet the typical worker's spending needs in retirement.”

Something of a hedge in confidence for a product that continues to generate controversy, but a report released Thursday from Morningstar details where target-date funds reside in their industry development.

The report, “Target-Date Series Research Paper: 2013 Industry Survey,” finds target-date series have become “established fixtures in defined contribution plans: assets are rising, fees are falling, and performance reflects strong broad market trends.”

It notes more target-date assets are shifting to passively managed investments, as both an underlying holding within a portfolio and as an overall investment approach. While 68% of target-date assets were in actively managed series as of Dec. 31, inflows to passively managed series—those that invest 80% or more in passively managed investments—surpassed flows into actively managed series for the first time for the 2012 calendar year.

Top 5 Sliver Stocks To Watch Right Now: Sterlite Industries(India)

Sterlite Industries (India) Limited operates as a non-ferrous metals and mining company in India and internationally. It engages in the smelting and processing of copper and production of copper byproducts. The company?s primary products consist of copper cathode and continuos cast rods, as well as by products comprise sulphuric acid, phosphoric acid, hydrofluoro silicic acid, gypsum, ferro sand, and slime. It also owns the Mt. Lyell copper mine at Tasmania in Australia, as well as owns various zinc assets, including Skorpion Zinc in Namibia; Black Mountain Mines in South Africa; and Lisheen Mines in Ireland. In addition, the company produces aluminum from its bauxite mines. Its aluminum products include aluminum ingots and wire rods; rolled products, such as coils and sheets; and vanadium sludge as a by-product. Further, the company smelts and produces lead and zinc, as well as produces and sells sulphuric acid to fertilizer manufacturers and other industries; and silver ingots primarily to industrial users. It operates three lead-zinc mines in the state of Rajasthan, northwest India. Additionally, it involves in power generations business. As of March 31, 2011, the company had a power generation capacity of 1,041 MW from its thermal power plants and wind power plants. The company was formerly known as Sterlite Cables Limited and changed its name to Sterlite Industries (India) Limited in 1986.The company was incorporated 1975 and is based in Mumbai, India. Sterlite Industries (India) Limited is a subsidiary of Vedanta Resources plc.

Advisors' Opinion:

• [By Rajhkumar K Shaaw]

  BNP Paribas Securities (Asia) Ltd., Macquarie Capital Securities (India) Pvt. and Ambit Capital Pvt. cut their Sensex targets as the Reserve Bank of India unexpectedly increased its benchmark interest rate to stem a record decline in the rupee and curb consumer prices in the world�� second-most populous nation. Strategists reduced their average profit estimate by 4.5 percent as higher borrowing costs threaten to worsen the slowest economic expansion since 2009.

Top 5 Rising Stocks To Own For 2014: Arctic Cat Inc.(ACAT)

Arctic Cat Inc. designs, engineers, manufactures, and markets snowmobiles and all-terrain vehicles (ATVs) under the Arctic Cat brand name in the United States and internationally. It also offers related parts, garments, and accessories. The company provides replacement parts and accessory items, such as electric start and reverse kits, luggage racks and bags, backrests, machine covers, windshields, and colored accessories; and maintenance supplies consisting of oil and fuel additives, track studs, and carbide runners for snow mobiles. It also provides ATV parts and accessories, including winch kits, snow plow kits, MRP Speedrack accessories, portable lights, utility bags, track kits, Speedpoint attachments, and maintenance supplies. In addition, the company offers snowmobile and ATV garments for adults and children under the Arcticwear and Arcticwear ATV Gear label. Its garment portfolio includes suits, jackets, pants, accessory garments, pull-overs, riding gloves, hats, b oots, gear bags, sweatshirts, t-shirts, caps, and helmets. The company markets its products through a network of independent dealers in the United States, Canada, and Europe; and through distributors representing dealers in the Middle East, Asia, and other international markets. Arctic Cat Inc. was founded in 1982 and is based in Plymouth, Minnesota.

Advisors' Opinion:

• [By Dan Caplinger]

  Vail Resorts (NYSE: MTN  ) will release its quarterly report on Monday, and already, investors are celebrating an early cold snap in the American West by sending the resort company's stock toward yearly highs. To an even greater extent than winter-equipment makers Polaris Industries (NYSE: PII  ) and Arctic Cat (NASDAQ: ACAT  ) , Vail Resorts relies on a solid snow season in order to get visitors to come to its ski properties and stay at its resorts.

Top 5 Rising Stocks To Own For 2014: Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes-protease (partnered with AbbVie, the former research-based pharmaceutical business of Abbott Laboratories), NS5A (partnered with Novartis) and nucleotide polymerase, as well as a host targeted antiviral (HTA) inhibitor class targeted against cyclophilin. ABT-450, discovered through its collaboration with AbbVie, is a protease inhibitor that has demonstrated in vitro potency against known resistant HCV mutants.

In Phase I studies, ABT-450 co-administered with ritonavir, a commonly used boosting agent to increase the blood concentrations of many protease inhibitors, was shown to be safe and well tolerated. Co-administration of ABT-450 with ritonavir, which it refers to together as ABT-450/r, has enabled once-daily dosing of ABT-450. Phase II studies have demonstrated the efficacy of ABT-450/r in patients with chronic HCV, and other interferon-free Phase II studies of ABT-450-containing regimens continue. AbbVie is developing a next-generation protease inhibitor discovered within the Enanta-AbbVie collaboration. EDP-239 is the NS5A inhibitor discovered by the Company. The Company also has a program to develop nucleotide inhibitors to HCV NS5B polymerase, which is another DAA mechanism considered to have a barrier to resistance. The Company�� Bicyclolide antibiotic product candidate is EDP-788, which it is developing for use as an intravenous drug in the hospital setting and for oral dosing in the home setting. EDP-788 is a prodrug, which means that it is inactive until it is converted in the body into an active compound. EDP-788 is! a water-soluble molecule which, when administered in preclinical models, is cleanly and rapidly converted into the active compound.

Advisors' Opinion:

• [By James Fink]

  And lastly I'll go into healthcare, which is kind of a growth cyclical type name. It's partially defensive, partially growth. I think the more growth-oriented section of healthcare would be biotech, and right now, a very promising biotech stock is Enanta Pharmaceuticals. That's a NASDAQ stock; ticker symbol (ENTA).

• [By George Budwell]

  Normally, such strong efficacy results would be hailed as a major achievement. However, these results are actually less impressive than those by competing drug's developed by AbbVie (NYSE: ABBV  ) , Enanta Pharmaceuticals (NASDAQ: ENTA  ) and Gilead. Bristol-Myers' therapy also has a treatment duration double that of Gilead's drug Sovaldi for genotype 1 patients. So, while these results are impressive in their own right, the therapy's commercial prospects may be limited due to the presence of superior competitors in the market.�

Top 5 Rising Stocks To Own For 2014: Emeritus Corporation (ESC)

Emeritus Corporation operates senior living communities in the United States. The company�s communities offer Alzheimer�s and dementia care, independent living, assisted living, specialized memory care, and skilled nursing care services. It also provides management services to independent and related-party owners of assisted living communities. As of November 15, 2012, the company operated approximately 470 senior living communities in 44 states with a resident capacity for approximately 50,000 residents. Emeritus Corporation was founded in 1993 and is headquartered in Seattle, Washington.

Advisors' Opinion:

• [By John Kell]

  Brookdale Senior Living Inc.(BKD) has agreed to merge with Emeritus Corp.(ESC) in a deal that values the operator of long-term, assisted-living facilities at about $1.4 billion, as the companies look to form a national senior-living-solutions company. Emeritus surged 34% to $28.75 premarket.

• [By Lisa Levin]

  Emeritus (NYSE: ESC) shares gained 3.20% to touch a new 52-week high of $33.18. Emeritus shares have jumped 31.71% over the past 52 weeks, while the S&P 500 index has gained 16.93% in the same period.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Emeritus (NYSE: ESC  ) , whose recent revenue and earnings are plotted below.